PHAR
Pharming Group

913
Mkt Cap
$1.2B
Volume
8,047.00
52W High
$17.86
52W Low
$7.50
PE Ratio
1,213.89
PHAR Fundamentals
Price
$17.55
Prev Close
$17.48
Open
$17.54
50D MA
$15.33
Beta
0.45
Avg. Volume
21,814.05
EPS (Annual)
-$0.1761
P/B
4.53
Loading...
Loading...
News
all
press releases
Pharming Group (OTCMKTS:PHGUF) Sets New 52-Week High - Time to Buy?
Pharming Group (OTCMKTS:PHGUF) Hits New 12-Month High - Here's What Happened...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Pharming Group (NASDAQ:PHAR) Sees Large Volume Increase - Should You Buy?
Pharming Group (NASDAQ:PHAR) Sees Strong Trading Volume - Here's Why...
MarketBeat·3d ago
News Placeholder
Pharming Group (NASDAQ:PHAR) Stock Price Up 11% - Time to Buy?
Pharming Group (NASDAQ:PHAR) Stock Price Up 11% - What's Next...
MarketBeat·6d ago
News Placeholder
Pharming Group (NASDAQ:PHAR) Sees Strong Trading Volume - What's Next?
Pharming Group (NASDAQ:PHAR) Sees Strong Trading Volume - Here's What Happened...
MarketBeat·9d ago
News Placeholder
Pharming Group (NASDAQ:PHAR) Shares Gap Down - Here's Why
Pharming Group (NASDAQ:PHAR) Shares Gap Down - Time to Sell...
MarketBeat·12d ago
News Placeholder
Pharming Group (NASDAQ:PHAR) Sets New 12-Month High - Still a Buy?
Pharming Group (NASDAQ:PHAR) Reaches New 52-Week High - Here's What Happened...
MarketBeat·14d ago
News Placeholder
Wall Street Analysts Believe Pharming Group (PHAR) Could Rally 81.71%: Here's is How to Trade
The mean of analysts' price targets for Pharming Group (PHAR) points to an 81.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks·15d ago
News Placeholder
Pharming Group (OTCMKTS:PHGUF) Hits New 52-Week High - Here's What Happened
Pharming Group (OTCMKTS:PHGUF) Sets New 1-Year High - What's Next...
MarketBeat·19d ago
News Placeholder
Pharming Group (NASDAQ:PHAR) Sees Strong Trading Volume - Should You Buy?
Pharming Group (NASDAQ:PHAR) Sees Strong Trading Volume - Still a Buy...
MarketBeat·21d ago
News Placeholder
Arcutis Biotherapeutics, Inc. (ARQT) Soars to 52-Week High, Time to Cash Out?
Arcutis Biotherapeutics (ARQT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks·21d ago

Latest PHAR News

View

Advertisement|Remove ads.

Advertisement|Remove ads.